Ion Beam Applications SA

PINK:IOBCF USA Medical Devices
Market Cap
$303.34 Million
Market Cap Rank
#14957 Global
#5942 in USA
Share Price
$10.35
Change (1 day)
-12.29%
52-Week Range
$10.35 - $12.49
All Time High
$57.64
About

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. Thi… Read more

Ion Beam Applications SA (IOBCF) - Net Assets

Latest net assets as of June 2025: $118.98 Million USD

Based on the latest financial reports, Ion Beam Applications SA (IOBCF) has net assets worth $118.98 Million USD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($626.99 Million) and total liabilities ($508.01 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $118.98 Million
% of Total Assets 18.98%
Annual Growth Rate -5.19%
5-Year Change -21.79%
10-Year Change -32.21%
Growth Volatility 27.19

Ion Beam Applications SA - Net Assets Trend (2001–2024)

This chart illustrates how Ion Beam Applications SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Ion Beam Applications SA (2001–2024)

The table below shows the annual net assets of Ion Beam Applications SA from 2001 to 2024.

Year Net Assets Change
2024-12-31 $110.92 Million +4.44%
2023-12-31 $106.21 Million -8.40%
2022-12-31 $115.95 Million -7.90%
2021-12-31 $125.90 Million -11.24%
2020-12-31 $141.83 Million +27.38%
2019-12-31 $111.34 Million +8.00%
2018-12-31 $103.09 Million -5.15%
2017-12-31 $108.69 Million -27.73%
2016-12-31 $150.39 Million -8.09%
2015-12-31 $163.63 Million +52.18%
2014-12-31 $107.53 Million +59.92%
2013-12-31 $67.24 Million +16.61%
2012-12-31 $57.66 Million -16.09%
2011-12-31 $68.72 Million -54.91%
2010-12-31 $152.40 Million +5.73%
2009-12-31 $144.14 Million -5.40%
2008-12-31 $152.37 Million +7.69%
2007-12-31 $141.48 Million +3.78%
2006-12-31 $136.33 Million +31.24%
2005-12-31 $103.88 Million -43.73%
2004-12-31 $184.62 Million +1.91%
2003-12-31 $181.16 Million -45.13%
2002-12-31 $330.15 Million -12.55%
2001-12-31 $377.54 Million --

Equity Component Analysis

This analysis shows how different components contribute to Ion Beam Applications SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 3944000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings $39.44 Million 35.56%
Common Stock $42.50 Million 38.32%
Other Comprehensive Income $1.36 Million 1.23%
Other Components $27.62 Million 24.90%
Total Equity $110.92 Million 100.00%

Ion Beam Applications SA Competitors by Market Cap

The table below lists competitors of Ion Beam Applications SA ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ion Beam Applications SA's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 106,212,000 to 110,924,000, a change of 4,712,000 (4.4%).
  • Net income of 9,253,000 contributed positively to equity growth.
  • Dividend payments of 4,889,000 reduced retained earnings.
  • New share issuances of 1,436,000 increased equity.
  • Other comprehensive income decreased equity by 1,032,001.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $9.25 Million +8.34%
Dividends Paid $4.89 Million -4.41%
Share Issuances $1.44 Million +1.29%
Other Comprehensive Income $-1.03 Million -0.93%
Other Changes $-56.00K -0.05%
Total Change $- 4.44%

Book Value vs Market Value Analysis

This analysis compares Ion Beam Applications SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.75x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.68x to 2.75x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2001-12-31 $15.23 $10.35 x
2002-12-31 $13.34 $10.35 x
2003-12-31 $7.38 $10.35 x
2004-12-31 $7.49 $10.35 x
2005-12-31 $4.10 $10.35 x
2006-12-31 $5.14 $10.35 x
2007-12-31 $5.21 $10.35 x
2008-12-31 $5.82 $10.35 x
2009-12-31 $5.39 $10.35 x
2010-12-31 $5.70 $10.35 x
2011-12-31 $2.55 $10.35 x
2012-12-31 $2.16 $10.35 x
2013-12-31 $2.51 $10.35 x
2014-12-31 $3.79 $10.35 x
2015-12-31 $5.60 $10.35 x
2016-12-31 $5.10 $10.35 x
2017-12-31 $3.68 $10.35 x
2018-12-31 $3.52 $10.35 x
2019-12-31 $3.78 $10.35 x
2020-12-31 $4.77 $10.35 x
2021-12-31 $4.17 $10.35 x
2022-12-31 $3.84 $10.35 x
2023-12-31 $3.65 $10.35 x
2024-12-31 $3.76 $10.35 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ion Beam Applications SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 8.34%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 1.86%
  • • Asset Turnover: 0.81x
  • • Equity Multiplier: 5.55x
  • Recent ROE (8.34%) is above the historical average (-3.96%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2001 -6.44% -9.44% 0.33x 2.05x $-61.43 Million
2002 -6.65% -7.99% 0.39x 2.11x $-54.45 Million
2003 -68.88% -49.24% 0.51x 2.77x $-142.78 Million
2004 3.37% 3.30% 0.55x 1.87x $-12.23 Million
2005 2.95% 2.24% 0.67x 1.96x $-7.29 Million
2006 22.09% 17.62% 0.64x 1.96x $16.42 Million
2007 9.89% 6.51% 0.66x 2.30x $-152.60K
2008 3.51% 1.60% 0.65x 3.36x $-9.84 Million
2009 3.72% 1.60% 0.69x 3.35x $-9.01 Million
2010 4.12% 1.61% 0.73x 3.49x $-8.90 Million
2011 -124.50% -35.39% 0.48x 7.37x $-90.89 Million
2012 -10.06% -2.62% 0.57x 6.70x $-11.57 Million
2013 -1.50% -0.48% 0.75x 4.19x $-7.73 Million
2014 22.59% 11.01% 0.72x 2.86x $13.54 Million
2015 37.39% 22.63% 0.68x 2.42x $44.83 Million
2016 16.25% 7.43% 0.86x 2.53x $9.40 Million
2017 -36.07% -13.64% 0.86x 3.06x $-50.07 Million
2018 -4.27% -1.71% 0.66x 3.80x $-14.71 Million
2019 6.83% 2.69% 0.66x 3.82x $-3.52 Million
2020 22.51% 10.23% 0.61x 3.60x $17.74 Million
2021 3.08% 1.24% 0.57x 4.34x $-8.71 Million
2022 5.22% 1.68% 0.58x 5.38x $-5.54 Million
2023 -8.58% -2.12% 0.72x 5.63x $-19.73 Million
2024 8.34% 1.86% 0.81x 5.55x $-1.84 Million

Industry Comparison

This section compares Ion Beam Applications SA's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $694,749,556
  • Average return on equity (ROE) among peers: -25.46%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Ion Beam Applications SA (IOBCF) $118.98 Million -6.44% 4.27x $202.91 Million
Advanced Biomedical Technologies Inc (ABMT) $-4.46 Million 0.00% 0.00x $14.18K
Abbott Laboratories (ABT) $4.82 Billion 39.04% 1.31x $191.37 Billion
Acarix AB (publ) (ACIXF) $1.93 Million -127.02% 0.21x $26.42 Million
Adagio Medical Holdings, Inc Common Stock (ADGM) $-72.62 Million 0.00% 0.00x $4.05 Million
Adm Tronics Unltd (ADMT) $-12.69K 0.00% 0.00x $3.17 Million
Aethlon Medical Inc (AEMD) $-3.07 Million 0.00% 0.00x $2.79 Million
Acutus Medical Inc (AFIB) $126.58 Million -80.56% 0.52x $732.88K
Adapthealth Corp (AHCO) $2.07 Billion 7.56% 1.54x $914.25 Million
Allied Healthcare Products Inc. (AHPIQ) $8.88 Million -33.95% 1.22x $726.24
20/20 Biolabs, Inc. Common Stock (AIDX) $3.39 Million -59.65% 0.38x $9.18 Million